#31 AI & Digital Twins: The Next Evolution for Personalised Medicine

In this episode of Dev and Doc, we deep dive into the world of Digital Twins. Popularised in engineering, we explore key concepts and ideas before looking to the future: how we can combine digital twins with today's powerful AI /GPT-based models (LLMs) and healthcare data to bring on a new revolution of healthcare to the world.This means the chance for every single person to create digital twins of themselves where they can understand their personal health, risks, disease trajectories, and treatment outcomes by simulating the future. This is the true promise of precision medicine for all. Crazy, right?Dev and Doc recently joined forces to build this exact vision in their start-up, Nuraxi.🚀 Nuraxi is a deep-tech company focused on advancing health and precision medicine through artificial intelligence and digital twin technology. https://www.nuraxi.ai/👋 Hey! If you are enjoying our conversations, reach out, share your thoughts and journey with us. Don't forget to subscribe whilst you're here :)Timestamps:00:00 - Intro: Digital Twin (DT)01:22 - Start / Introduction to DT08:28 - Levels of DTs18:33 - Using natural language to capture biology complexities and scales26:45 - First time in humanity: Combination of AI, compute, healthcare data, and wearables33:15 - Building Agentic Health Twins at Nuraxi38:15 - Combining AI and Digital Twins: GPT-based simulations of the future44:20 - To change healthcare, we must be able to predict the future49:10 - Future directions: From molecular and organ twins to Population TwinsThe Hosts:👨🏻‍⚕️ Doc - Dr. Joshua Au YeungLinkedIn Profile🤖 Dev - Zeljko KraljevicTwitter ProfileReferences:• Nuraxi: Website• EU's Earth Twin: Destination Earth• Blog on language representation of biology: Read here• Foresight GPT (The Lancet): Read PaperListen & Subscribe:📺 YouTube🎧 Spotify🍏 Apple Podcasts📝 SubstackCredits:📧 Enquiries: [email protected]🎞️ Editor: Dragan Kraljević (Instagram)🎨 Brand Design: Ana Grigorovici (Behance)

There are no comments yet.

Please log in to write the first comment.